Two years on, the events of October 7 remain deeply contested. The narrative that emerges depends as much on interpretation ...
Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily.
T-cell therapy has revolutionised the treatment of B-cell malignancies, offering durable responses for patients with relapsed or refractory disease. However, access globally remains limited due to ...